Diadema Partners »

Macrogenics shares owned by Diadema Partners

Quarter-by-quarter ownership of Macrogenics (MGNX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Macrogenics

Tip: Access up to 7 years of quarterly data

All positions including Macrogenics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Macrogenics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7M 600k 2.89

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Macrogenics

Armistice Capital
Renaissance Technologies
Millennium Management
Vanguard Capital Management
Acadian Asset Management
Two Sigma Investments
Bank of America Corporation
Marshall Wace
Daniel D. Thurber
RA Capital Management
Vanguard Portfolio Management
BlackRock
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management
Citadel Advisors

View all funds holding Macrogenics